The effects of switching from etelcalcetide to upacicalcet in hemodialysis patients with secondary hyperparathyroidism
These findings suggested that upacicalcet may be a useful option for managing serum P levels in hemodialysis patients with SHPT.
Authors
- Hongmei Lü (ORCID: https://orcid.org/0000-0002-4686-4491)
- Mari Urata
- Mayuko Amaha
- Tsukasa Nakamura
- Manaka Degawa
- Eiichi Sato (ORCID: https://orcid.org/0000-0002-2238-9200)
- Noriaki Moriyama
- Takao Ono (ORCID: https://orcid.org/0000-0002-0498-8293)
- Shohei Sato
- Mayumi Nomura
- Daisuke Matsumura (ORCID: https://orcid.org/0000-0001-6087-7021)
Publication Details
- Journal
- Clinical Nephrology
- Published
- 2025-08-20
- DOI
- https://doi.org/10.5414/cn111695
- Primary Topic
- Parathyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00